Pfiz­er-backed de­cen­tral­ized co­op­er­a­tive rais­es $4.1M to fund longevi­ty re­search

Months af­ter Pfiz­er Ven­tures put a de­cen­tral­ized co­op­er­a­tive on the map by an­nounc­ing a $500,000 in­fu­sion in­to its mis­sion of fund­ing hu­man longevi­ty re­search, the group — Vi­taDAO — is ty­ing the bow around a $4.1 mil­lion fundrais­ing round.

As its name im­plies, Vi­taDAO calls it­self a DAO, or de­cen­tral­ized au­tonomous or­ga­ni­za­tion. Like many oth­er such groups, it aims to run on a rel­a­tive­ly flat, glob­al struc­ture us­ing con­tracts on blockchains and cryp­to-tied to­kens in hopes of prov­ing a new way to fund big ideas and bridge the val­ley of death for very ear­ly-stage re­search on an­ti-ag­ing.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER